Patient self management of oral anticoagulation;Die patientenselbstkontrolle der oralen antikoagulation

Therapeutische Umschau

Volumn 60, Issue 1, 2003, Pages 59-62

  Caliezi, C ^a   Niederer, A ^b   Wuillemin, W A ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN; THROMBOPLASTIN;

ANTICOAGULATION; BLEEDING; CLINICAL TRIAL; HUMAN; INTERNATIONAL STANDARD UNIT; LONG TERM CARE; QUALITY CONTROL; QUALITY OF LIFE; REVIEW; SELF MEDICATION; SWITZERLAND; THROMBOEMBOLISM; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG MONITORING; ECONOMICS; FEMALE; HEALTH INSURANCE; HEART VALVE PROSTHESIS; INSTRUMENTATION; INTERNATIONAL NORMALIZED RATIO; MALE; MONITORING; ORAL DRUG ADMINISTRATION; PATIENT EDUCATION; PATIENT SELECTION; PHOTOMETRY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SELF CARE; STANDARD; TIME;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CHILD; DRUG MONITORING; FEMALE; HEART VALVE PROSTHESIS; HUMANS; INSURANCE, HEALTH; INTERNATIONAL NORMALIZED RATIO; MALE; MONITORING, PHYSIOLOGIC; PATIENT EDUCATION; PATIENT SELECTION; PHOTOMETRY; PROSPECTIVE STUDIES; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SELF CARE; THROMBOPLASTIN; TIME FACTORS;

EID: 0037257374     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.60.1.59     Document Type: Review

References (17)

1. White RH, McCurdy SA, von Marensdorff H, Woodruff DE Leftgoff L. Home prothrombin time monitoring after the initiation of warfarin therapy. Ann Intern Med 1989; 111: 730-7.
2. Anderson D, Harrison L Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993; 153: 1441-7.
3. Hasenkamm JM, Knudsen L, Kimose HH, et al. Practicability of patient self-testing of oral anticoagulant therapy by the international normalized ratio (INR) using a portable whole blood monitor. Thromb Res 1997; 85: 77-82.
4. Ansell JE, Patel N, Ostrovsky D, et al. Long term patient self management of oral anticoagulation. Arch Intern Med 1995; 155: 2185-9.
5. Cromheecke M, Levi M, Colly LP, et al. Oral anticoagulation self management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000; 356: 97-102.
6. Watzke HH, Forberg E, Svolba G, Jimenez-Boj E, Krinninger B. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 2000; 83: 661-5.
7. Körtke H, Minami K, Breymann T, et al. INR-Selbstmanagement nach mechanischem Herzklappenersatz: ES-CAT (Early self controlled anticoagulation trial). Z Kardiol 2001; 90: VI 118-VI24.
8. Kulinna W, Ney D, Wenzel T, Heene DL Harenberg J. The effect of self-monitoring the INR on quality of anticoagulation and quality of life. Sem Thromb Haemost 1999; 25: 123-6.
9. Caliezi C, Waber M, Pfiffner D, et al. Patienten-Selbstkontrolle der oralen Antikoagulation mit CoaguChek. Schweiz Med Wochenschr 2000; 130: 916-23.
10. Van den Besselaar AMP, Breddin K, Lutze G, et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coagulation and Fibrinolysis 1995; 6: 726-32.
11. Kaatz SS, White RH, Hill J, et al. Accuracy of laboratory and portable monitor international normalized ratio determinations. Arch Intern Med 1995; 155: 1861-7.
12. Wuillemin WA, Burri S, Lämmle B. Quick-Messungen aus Kapillar-Blut mittels CoaguChek oder CoaguChek Plus. Labolife 1997; 3: 1-4.
13. Kapiotis S, Quehenberger P, Speiser W. Evaluation of the new method CoaguChek for the determination of prothrombin time from capillary blood: comparison with Thrombotest on KC-1. Thromb Res 1995; 77: 563-7.
14. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. Ann Intern Med 2000; 133: 687-95.
15. Bernardo A, Bernardo A, Leinberger R, Taborski U Zerback R. Thromboplastinzeit-Selbstbestimmung mit dem CoaguChek System. Herz/Kreisl. 1995; 27: 71-5.
16. Bernardo A. Optimierung der Langzeit-Antikoagulation durch Patienten-Selbstmanagement? Z Kardiol 1998; 87: 75-81.
17. Taborski U, Wittstamm FJ, Bernardo A. Cost-effectiveness of self-managed anticoagulant therapy in Germany. Sem Thromb Haemost 1999; 25: 103-7.